AI biomedical research

Causaly scores $60M to enhance AI platform for biomedical research

Published On: September 8, 2023Categories: Technology

By Jessica Hagen

Causaly, a tech company using AI to interpret large datasets and literature, announced it closed a $60 million Series B round led by ICONIQ Growth.

Marathon Venture Capital, Index Ventures, Pentech Ventures, EBRD and Visionaries Club also participated in the round, as did former chairman and CEO of Johnson & Johnson Alex Gorsky and CEO and cofounder of Datadog Olivier Pomel.

Continue Reading

news via inbox

Stay on the cutting edge of medicine with the PLMI Newsletter.